Stem cells have the unique potential to divide asymmetrically to generate daughters with distinct fates, one which remains a stem cell and the other which turns into a cell committed to differentiation. By dividing asymmetrically, stem cells maintain the stem cell pool and simultaneously generate committed cells that reconstitute the organ, for example, to prepare the breast for a new pregnancy after involution from a previous pregnancy and lactation process. In addition to the in vivo models of mammary morphogenesis, there are in vitro systems that make the ductulogenic pattern of breast epithelia growth more amenable to study in critically determined conditions. The human breast epithelial cells MCF-10F formed tubules when grown in type I collagen and we demonstrated that treatment of these cells with 17b-estradiol (E 2 ) induces phenotypical changes indicative of neoplastic transformation. The transformation of MCF-10F by E 2 is associated with impaired ductal morphogenesis caused by an alteration of the stem cells unique potential to divide asymmetrically, inducing formation of solid masses and mimicking intraductal carcinoma that progresses into an invasive and tumorigenic phenotype. In the present work, we present evidence for the mechanism of cell asymmetry which leads to normal ductulogenesis and show how the normal stem cell is transformed into a cancer stem cell by altering this process. Furthermore, we demonstrate that the carcinogenic agent, in this case E 2 , induces a defect in the asymmetric cell division program of the normal mammary stem cell.
Introduction
One unresolved and challenging question in breast cancer is whether the cancer stem cell originates from normal stem/ progenitor cells or from mature cells that have acquired stem cell phenotypes because of a transformation event or subsequent mutations. There is evidence that in the human breast there is a stem cell population that could give rise to many different cell types which are important for breast development, pregnancy induced differentiation, lactation and involution (1) . Stem cells have the unique potential to divide asymmetrically to generate daughters of distinct fate, one which remains a stem cell and the other which turns into a cell committed to differentiation. By dividing asymmetrically, stem cells maintain the stem cell pool and simultaneously generate committed cells that reconstitute the organ, for example, preparing the breast for a new pregnancy after the involution from a previous pregnancy and lactation process (2, 3) . Despite this cumulative knowledge we still do not know whether the cancer stem cell originates from normal stem/progenitor cells or from mature cells that have acquired stem cell phenotypes because of a transformation event or subsequent mutations. Our starting hypothesis is that the normal stem cell divides asymmetrically and that the carcinogenic event disrupts this process, leading to a neoplastic breast cancer stem cell. Furthermore, the main challenge has been to demonstrate that the asymmetric cell division takes place in the normal process of ductulogenesis and that the carcinogenic agent (17b-estradiol) modifies this process (4) (5) (6) . This unique model offers the opportunity to understand a stem cell with basal cell type characteristics that differentiates normally in a tri-dimensional in vitro system forming ductular structures and mimicking lobules type 1 of the human breast (4) (5) (6) . This in turn offers a structural model which helps us understand how normal cellular architecture is modified during asymmetric cell division and how it operates as the main driver of this normal morphogenetic process. In addition, the basal stem cell, when challenged by a carcinogenic agent, loses the ability to form ductal structures and becomes neoplastic, mimicking the histological appearance of the early neoplastic process, such as carcinoma in situ, forming an epithelial multilayer with a loss of polarity and an increase in cell proliferation (5, 6) . Therefore, through this unique system we have been able to demonstrate that under a carcinogenic insult the normal stem cell is the one that switches the process of asymmetric cell division. Altogether, this model is offering a way of understanding the mechanism of asymmetric cell division that is still elusive in breast cells and demonstrating how the disruption of this phenomenon by estrogen can trigger the initial step of cell transformation.
There are four main sets of data that support this hypothesis: (i) the model of human breast epithelial cell transfor- mation in vitro in the context of breast cancer, (ii) the basal cell as the normal stem cell that generates the ductal structures, (iii) demonstration that the basal cell type is a stem cell of breast cancer, and (iv) genomic alterations in the transformed (trMCF) cells indicate that asymmetric cell division is the target mechanism of neoplastic transformation.
The model of human breast epithelial cell transformation in vitro in the context of breast cancer
Invasive breast cancer that leads to metastasis is a heterogeneous disease that encompasses a variety of pathological features that are associated with specific clinical behavior (7) . The discovery that the morphological heterogeneity of breast cancer is reflected at the transcriptome level has allowed the classification of breast cancer into five main groups: luminal A and B, normal breast-like, ERBB2 (HER2), and basal-like breast carcinomas (8, 9) . The luminal-like subtypes display moderate to high expression of estrogen receptor alpha (ERa) and luminal cytokeratins. The basal-like carcinomas, which have been reported to have more aggressive clinical behavior, are the carcinomas we will concentrate our attention on as the basis for demonstrating our hypothesis that the normal stem cell divides asymmetrically and that the carcinogenic event disrupts this process leading to a neoplastic cancer stem cell. The basal-like carcinomas are composed of cells that consistently express genes usually found in normal basal/myoepithelial cells of the breast, including basal cytokeratins, such as 5/6, 14, and 17, p-cadherin, and caveolin 1 and p53 (10, 11) . Molecular analyses of basal-like carcinomas have confirmed the frequent lack of expression of estrogen (ER) (12, 13) and progesterone (PR) receptors and HER2 (14, 15) , high expression levels of proliferation-related genes, and frequent mutations of the TP53 gene. Morphologically, basal-like breast carcinomas present with high histological grade, high mitotic indices, central necrotic zones, pushing borders and a conspicuous lymphocytic infiltrate. In addition, metaplastic elements and medullary/atypical medullary features have been reported. Similarities have been found between basal-like tumors and breast carcinomas occurring in BRCA1 mutation carriers in a premenopausal population of African American (AA) women and in the younger breast cancer patient population in general (16, 17) .
Our observation that ductal carcinomas originate in lobules type 1 (Lob.1) of the immature breast ( Figure 1 ) (18), which are the structures with the highest proliferative activity, provides a mechanistic explanation for the higher susceptibility of these structures to neoplastic transformation when exposed to chemical carcinogens, as demonstrated in in vitro experiments (19) . However, the role of ERa positive and ERa negative cells in the initiation of breast cancer is not clear. The fact that the cells that do proliferate in culture are ERa negative suggests that the stem cells that originate normal ductal structures, and cancer, are the ERa negative proliferating cells. This concept is supported by our observation that MCF-10F, a spontaneously immortalized ERa negative human breast epithelial cell line derived from breast tissues containing Lob.1 and Lob.2 (20) , is able to form normal ductal structures in a tri-dimensional collagen matrix system (Figures 2A and 3) . The ductal structures are lined by a monolayer of well polarized epithelial cells that become malignant after exposure to the chemical carcinogens benz(a)pyrene (19) were poorly differentiated ERa, PR, and ERBB2 negative adenocarcinomas (5, 6) . These characteristics are similar to the human basal cell-like carcinomas previously described (9) . To better understand the molecular events associated with the progressive phenotypic changes that were observed during estrogen-mediated malignant cell transformation, we analyzed chromosomal copy number (CN), loss of heterozygosity (LOH), and gene expression changes that occurred at different stages of cell transformation. By integrating these data we were able to identify associations between CN changes, LOH, transcript expression, and phenotypes of invasion and tumorigenicity, including a strong gene signature of epithelial to mesenchymal transition (EMT) that was confirmed by immunohistochemistry (6) . The bcMCF (invasive) and caMCF (tumor-derived) cells showed dramatic changes in morphology, losing epithelial characteristics of polarity and acquiring the mesenchymal characteristics of fibroblast-like spindle shapes and increased migratory behavior and invasiveness ( Figure 3 ). Changes in gene and protein expression were characteristic of EMT, namely loss of intercellular adhesion (E-cadherin and occludins), downregulation of epithelial makers (cytokeratins), and upregulation of mesenchymal markers (vimentin and smooth muscle actin) (5, 6) ( Figure 5 ).
The basal cell as the normal stem cell that generates the ductal structures MCF-10F cells grow in collagen matrix, providing a threedimensional architecture of the mammary gland in vitro (Figures 2A and 3) . One of the advantages of using type I collagen matrix is that the human breast epithelial cells, such as MCF-10F, form tubules mimicking the normal ductules of the human breast. After the cells are treated with E 2 , the E 2 treatment increased cell proliferation as evaluated using an antibody against Ki-67 antigen. The Ki67 antigen is a cell cycle related nuclear protein, expressed by proliferating cells in all phases of the active cell cycle (G1, S, G2, and M phase) and it is absent in resting (G0) cells. The cross-sections of the tubular structures showed a monolayer of epithelial cells around the lumen (Figure 3 ), whereas in the E 2 treated cells the cross-section of the tubules showed an increase of both number of epithelial layers ( Figure 3 ) and Ki-67 positive cells (proliferative indexs91.16). The epithelial cells layering the ducts proved to be ERa negative and have a significantly low expression of cadherins, laminin, and fibronectin. The filling of the lumen is the result of decreases in central apoptosis, enhanced cellular proliferation, or a combination of both (24) . Luminal filling is the earliest morphologic alteration and is commonly reported in neoplastic processes (24) . Luminal filling is commonly seen in atypical ductal hyperplasia and ductal carcinoma in situ. In summary, these phenotypical changes are representative of the phenomena observed in the breast and provide an adequate model for addressing the double question of the role of asymmetry in stem cell division and the role of a carcinogenic insult on the stem cell.
Demonstration that the basal cell type is a stem cell of breast cancer MCF-10F cells are non-transformed, non-tumorigenic, and ER negative. Because malignant cell transformation of these cells (4, 5, (21) (22) (23) produced poorly differentiated tumors characteristic of basal-like carcinomas, we chose to classify these cells relative to the breast cell lines described by Charafe-Jauffret et al. (25) . MCF-10F and derived cell lines clustered in the branch containing the basal breast cell lines. In our molecular characterization of malignant cell transformation (6), we identified the ''intermediate filament'' component enriched in gene ontology analysis, separating the non-tumorigenic MCF-10F and trMCF cells from the tumorigenic bcMCF and caMCF cells. Numerous cytokeratins were suppressed or absent, whereas vimentin was strongly induced in bcMCF (7.0-fold) and caMCF (8.1-fold). Because of these findings, we generated a gene list from published literature for EMT markers and their regulators (6). The 52 genes on this list were filtered by low stringency criteria of combined coefficient of variation )0.3 and 'present calls' in more than 30% of the samples. The 27 genes passing these criteria were used for sample and gene clustering ( Figure  5A ). Two sample groups and two gene groups were identified. The non-tumorigenic MCF-10F and trMCF cells were grouped into sample cluster k, whereas the tumorigenic bcMCF and caMCF cells were grouped into cluster l. On the other side, the genes were grouped into cluster a and b based on their expression pattern. The epithelial markers, E-cadherin, occludin, desmoplakin, and cytokertins were decreased, whereas the mesenchymal markers, fibronectin, vimentin, and N-cadherin, were increased in bcMCF and caMCF cells ( Figure 5A ). With real time RT-PCR it was confirmed that expression of FN1, S100A4, SNAI2, HRAS, and TGFb1 was increased, whereas CDH1 (E-cadherin) was decreased in bcMCF and caMCF cells (6) . Immunocytochemical analysis using antibodies against epithelial membrane antigen (EMA, also called MUC1) and E-cadherin displayed significant loss of these epithelial markers and increased expression of the mesenchymal marker vimentin in tumorigenic cells ( Figure 5B ). These findings confirmed the EMT phenotype revealed by gene expression profile in Figure 5A .
Genomic alterations in trMCF cells indicate that asymmetric cell division is the target mechanism of neoplastic transformation
Loss of ductulogenic capacity is the earliest phenotype observed during neoplastic transformation of MCF-10F by E 2 . Asymmetric cell division takes place as part of the normal process of ductulogenesis and this process is modified by the carcinogenic agent. Specifically, we have demonstrated that E 2 , acting on the basal cell type, induces architectural changes in the stemness, cell polarity, the partitioning of the cell component and the mitotic apparatus and the interaction with the niche or extracellular matrix.
Stemness in asymmetric cell
is the cell surface marker of tumorigenic breast cancer cells in which the tumorigenic capacity is further increased by additional expression of ESA. These cells are characterized by a 186-gene ''invasiveness'' gene signature that is associated with risk of death and metastasis in breast cancer (26) . CD24 encodes a small, heavily glycosylated cell-surface adhesion protein. CD44 undergoes extensive alternative splicing within its central region spanning exon 6a to 14, also termed as variable exon v1 to v10. The two variants expressed in our model are mRNA precursor variant 3 with exon 6a to 11 spliced out, and variant 4 with exon 6a to 14 spliced out, corresponding to CD44E and CD44H, respectively (27) . CD44H is mainly expressed in cells of lymphohematopoietic origin; it plays an important role in cell adhesion and its expression promotes tumor cell migration (28) . CD44E is preferentially expressed in epithelial cells and is involved in the recognition of a common determinant in CD44H and CD44E promoting homotypic cellular aggregation (29 Figure 6A-D) . The significant increase of CD44H and complete loss of CD44E might be a novel phenotype associated with tumorigenic capacity. In addition, the loss of ESA in bcMCF and caMCF indicated that ESA expression is not required for the tumorigenic capacity in our model. Table 1 and Figures 7 and 8 list some of the genes that might contribute to the alteration of cell partitioning during asymmetric cell division. Among them is NOTCH3, which is significantly downregulated in the estrogen-transformed cells that have lost the ability to form ductal components in the collagen matrix. As depicted in Figure 9 , NOTCH3 is polarized in its localization in MCF10F cells, and when the cell divides one of the daughter cells carries the expression of NOTCH3. Instead, most of the E 2 -treated cells, or trMCF, have very low or no expression of NOTCH3. We therefore postulate that NOTCH3 could be asymmetrically partitioned in breast epithelial cells and that daughter cells that are transformed by estradiol will have a loss of the expression of this gene.
Cell partitioning in asymmetric cell division
There is supporting evidence in the literature indicating that Notch-1 and Notch-3 have been shown to affect stem cell fates, which might also be evolutionarily conserved (30) (31) (32) (33) . Interestingly, the Notch pathway plays multiple roles in hematopoiesis, including differentiation, proliferation, and survival and might be critical for hematopoietic stem cell (HSC) activity (34, 35 (49, 50) , and UBE2S, all components of the ubiquitin pathway which lead to proteosome degradation and are significantly dysregulated in trMCF cells. This supports the interpretation that localization of this complex could be asymmetrically located in trMCF cells under the treatment with estradiol, and therefore disrupting the asymmetrical process. Of great interest is TRIM22, a functional E 3 ubiquitin ligase, that is ubiquitinated itself and downregulated in trMCF cells indicating a possible role in the partitioned position in the stem cells MCF (Table 1 ). There is 41-fold downregulation in trMCF when compared with the stem cell MCF. Its potential role in the cell asymmetry is suggested to us by the work of Herr et al. (40) , showing that human and rhesus TRIM22 localize to different subcellular compartments and that this difference can be assigned to the positively selected B30.2 domain. It is possible that TRIM22 is asymmetrically located in MCF cells and that during transformation the daughter cells, trMCF, lose or alternatively silence the expression of this gene. The fact that TRIM22 underwent self-ubiquitylation in vitro, in combination with the E 2 enzyme UbcH5B, and the ubiquitylation was dependent on its RING finger domain, which is further support for our hypothesis. Further evidence shows that TRIM22 could also be self-ubiquitylated in vivo. Importantly, TRIM22 was conjugated with polyubiquitin chains and stabilized by the proteasome inhibitor in 293T cells, suggesting that TRIM22 targeted itself for proteasomal degradation through the polyubiquitylation (41) . Another example of evidence that TRIM22 could be involved in the asymmetry of cell division is the finding that interferon induces TRIM22 as a p53 target gene, with possible involvement in proliferation and differentiation of leukemia cells. Expression of TRIM22 correlates inversely to differentiation, as TRIM22 is highly expressed in CD34(q) human bone marrow progenitor cells, but declines in mature populations. The erythroid lineage appears as a special case, as TRIM22 expression shows an extreme decrease during late erythroid maturation and is completely undetectable in nucleated erythroid populations in contrast to other lineages (42, 43) . A similar phenomenon has been reported in T cells (44) . Therefore it is possible that TRIM22 is compartmentalized in one of the poles of the stem cell MCF and that during the estrogen-induced transformation process the daughter, or trMCF, cells lost it completely.
Besides NOTCH3 there are other candidate proteins coded by the genes MLF1 (51-54), NEBL (55-58), PACS1 (59-61), SEC14L2 (62), TRIOBP (63-65), TSPAN1, and PSIP1 ( Table 1 ) that might have a regulatory effect on the partition distribution of proteins and organelles affecting Table 1 . Gene expressions are relative to the MCF-10F cells. Top graph shows the downregulated genes and the graph below shows the upregulated genes; ''*'' represents the genes that had p-0.001 compared with control and ''q'' represents p-0.03. asymmetric cell division. For example, the myeloid leukemia factor 1 (MLF1) expresses normally in a variety of tissues, including hematopoietic stem cells as well as in MCF cells, but it is unregulated several folds in trMCF cells (Table 1) . MFL1 is a negative regulator of cell cycle progression, functioning upstream of the tumor suppressor p53 (51, 53, 54) and stabilizing the activity of the tumor suppressor p53 by suppressing E 3 ubiquitin ligase. The shuttling of MFL1 is critical for the regulation of cell proliferation and a disturbance in the shuttling balance increases the susceptibility of the cell to oncogenic transformation (52) . This gene product is therefore a target for evaluation in the loss of asymmetric division induced by E 2 in the MCF cells. There are also three genes, PACS1 (59-61), SEC14L2 (62) , and TRIOBP (63) (64) (65) , that are significantly downregulated in trMCF cells, possibly because their role in cell sorting and interaction with actin filaments might play an unsuspected role in asymmetric cell division. c-Mitotic apparatus A significant amplification in the expression of Aurora Kinase B (AURKB), polo-like kinase 1(PLK1), centromere protein A (CENPA), and kinesin family member C(KIF2C), are observed in the E 2 cells with regard to the MCF10 cells (Table 1 and Figure 8 ). This could indicate that the dysregulation of these genes by the carcinogenic agent E 2 contributes to the alteration of the asymmetric pattern of cell division of the stem cell MCF. Supporting evidence for this is the knowledge that the binding of kinetochores to spindle microtubules during mitosis regulates the trafficking of macropinisomes to the cytoskeleton during antigen presentation. CENPA is a histone H3-like protein that is thought to be involved in the nucleosomal packaging of centromeric DNA. It is a marker of embryonic stem cells (66, 67) and is highly expressed in breast cancer cells. CEN-PA interacts with poly(ADP-ribose) polymerase 2 (PARP-2) in a cell cycle-dependent manner, accumulating at centromeres during prometaphase and metaphase, disassociating during anaphase, and disappearing from the centromeres by telophase (68, 69) . The KIF2C/mitotic centromere-associated kinesin (MCAK) is associated with the growth of breast cancer cells. It is expressed at undetectable levels in normal human tissues and upregulated in the trMC cells, as well as in breast cancer tissue. Treatment of breast cancer cells with small interfering RNA against KIF2C/MCAK effectively suppressed KIF2C/MCAK expression and inhibited the growth of the breast cancer cell lines T47D and HBC5 (70) . The importance of these kinetochore related proteins is that few-fold reductions in kinetochore-microtubule turnover, particularly in early mitosis, induce severe chromosome segregation defects. Interestingly enough, stimulation of microtubule dynamics at kinetochores restores stability to chromosomally unstable tumor cell lines, establishing a causal relationship between deregulation of kinetochore-microtubule dynamics and chromosomal instability. Thus, temporal control of microtubule attachment to chromosomes during mitosis is central to genome stability in human cells (71) . In the Drosophila sensory organ precursor cells, Aurora A regulates the asymmetrical localization of Numb (72) . Mammalian Auroras (member of the serine/threonine kinase family) regulate centrosome separation, chromosome segregation, and cytokinesis. Auroras are overexpressed in many cancers and high protein levels correlated with chromosomal instability (73) (74) (75) . A key regulator in the process of cell division is the PLK1. It controls cytokinesis, the final stage of cell division and is a novel player in maintaining genomic stability during DNA replication and is an important modulator of the DNA damage checkpoint. Importantly, it has been shown to be a link between developmental processes and the cell cycle machinery during asymmetric cell division in flies and worms (76, 77) . Therefore, the role of CENPA, KIF2A, KIF2B, and MCAK (KIF2C) in the asymmetric cell division of breast epithelial cells is a focus of our research.
Two genes, YPEL5 and EPLIN, identified by us, might have an unsuspected role in the control of asymmetric cell division in the human breast epithelial cells. YPEL5 gene is downregulated in the E 2 -transformed cells and the coded pro- Figure 9 Immunofluorescence studies of NOTCH3. MCF-10F and E 2 cells were plated onto round cover slips and grown overnight at 378C. Cells were fixed using 4% formaldehyde and incubated with the primary antibody (Anti-NOTCH3, Abcam 2 mg/mL; Anti-a-Tubulin, Sigma 2 mg/mL) for 50 min at room temperature. Slides were viewed and images were recorded using the Nikon Eclipse 2000-U C1 LSCM and a 40sNA 1.3 oil objective lens. Nikon EZ-C1 software (Nikon Corporation, Tokyo, Japan) was used to view the images. NOTCH3 is shown here in red, Tubulin is shown in green.
tein is localized to the centrosome and nucleus during interphase, and at the mitotic spindle during mitosis. This subcellular localization, in association with centrosome or mitotic spindle, suggests a novel function involved in cell division (78) . The second gene, EPLIN (epithelial protein lost in neoplasm; also known as Lima-1) ( Table 1 ) (79), is also significantly downregulated in trMCF cells and plays an important role in membrane ingression during the first phase of cytokinesis. The ingression phase generates a cleavage furrow, requiring co-operative function of the actin-myosin II contractile ring and septin filaments (80) . It is therefore possible to postulate that EPLIN plays an important role in the asymmetric cell division of the stem cell MCF and is silenced in trMCF cells. This concept is supported by data showing low levels of EPLIN in tumor tissues (81) . Of interest is that EPLIN couples with a-catenin and, in turn, links the cadherin-catenin complex to F-actin (82) . EPLIN is a substrate for extracellular signal-regulated kinase pathway (ERK). ERK phosphorylates Ser360, Ser602, and Ser692 on EPLIN in vitro and in intact cells. Phosphorylation of the Cterminal region of EPLIN reduces its affinity for actin filaments (83) . EPLIN increases the number and size of actin stress fibers and inhibits membrane ruffling induced by Rac, and the reduced expression might contribute to the motility of invasive tumor cells (84, 85) . These data indicate a need for detailed analysis of the architectural localization of these gene products in the MCF cells during the normal process of ductulogenesis and during the loss of the asymmetric properties of these cells induced by E 2 .
Cell polarity and asymmetric cell division As depicted in Table 1 , there are several genes that are significantly dysregulated in trMCF cells, such as CDC42, EPSL8L2, FLNB, FXYD3, and NRP2. Whereas the role of EPSL8L2, FLNB, FXYD3, and NRP2 are less clear, CDC42 is known to regulate the generation of cell polarity from yeast to man, and in a wide range of biological contexts, as well as the downstream target Par6 (86, 87) . Epithelial morphogenesis involves the establishment of an apical surface in an individual cell and the formation of cadherin-based adherents junctions and claudin-based tight junctions between adjacent cells. The accompanying reorganization of the actin and microtubule cytoskeletons, and polarized vesicle trafficking, reinforces these interactions, leading to a stable tissue of polarized cells. Expression of dominant-negative or constitutively active versions of Cdc42 in the dog kidney epithelial cell line MDCK, grown on a two-dimensional surface, leads to defective tight junction formation (typically a delay), as well as mislocalized delivery of basolateral proteins (87) (88) (89) (90) . Similar experiments performed with MDCK, grown in three dimensions to provide a more physiological growth context, have concluded that Cdc42 is required to form an apical surface through regulated trafficking of a vacuolar apical compartment (91, 92) . In Caco-2, a human intestinal epithelial cell line, Cdc42 generates polarized cysts with a single central lumen when grown in a three-dimensional matrix. Cdc42 is not required for the formation of an apical surface but is instead required to position the apical surface with respect to the growing three-dimensional structure. Cdc42 regulates apical surface positioning by controlling spindle orientation during cell division.
Cell positioning and asymmetric cell division The interrelation between extrinsic determinants (niche), stem cells, and the regulation of cell fate is better characterized in germ line cells of lower organisms (93, 94) . In mammalian cells, such as the breast epithelia, the three-dimensional organization is determined by the extracellular matrix. Among the proteins involved in this process are the E-cadherin and the bone morphogenetic protein. Both are expressed in the normal cells and lost in trMCF cells. In the Drosophila germinal stem cell of the female gonads, DEcadherin-mediated cell adhesion was shown to be essential for anchoring ovarian gonadal stem cells to their niches and stimulating their proliferation (95) . Decapentaplegic (Dpp) (the Drosophila homolog of human bone morphogenetic protein 2/4) is expressed in anterior somatic cells of the gonad and is essential for primordial germ cell (PGC) proliferation. PGC mutants for thick veins, an essential Dpp receptor, are impaired in their ability to clonally populate a niche, further suggesting that Dpp is one of the extrinsic mitotic signals that promote the clonal expansion of gonadal stem cells in the niche (96) . Recent studies identify osteoblasts and the bone morphogenic proteins (BMP) signaling pathway as potential in vivo regulators of the HSC niches. In mice, BMP signaling promotes the generation of astrocytes and mature myelinating oligodendrocytes in vivo but does not affect oligodendrocyte precursor development, suggesting tight regulation of BMP signaling to ensure proper gliogenesis.
The concept of asymmetric cell division also needs to be studied in the context of the activation of cell proliferation, apoptosis, and cell junction gene products that are significantly modified during the transformation of MCF cells. Some of these genes are listed in Table 1 , among them are TOP2A (97, 98) , MK62, RFC3, BIRC5 (99, 100), and GSN. Of interest is the upregulation of BIRC5, or Survivin (Table  1 and Figure 10 ), a member of the apoptosis inhibitor family protein. A vector-based small interfering RNAs (siRNAs) silenced Survivin expression in prostate cancer cells, resulting in significantly reduced cell proliferation and enhanced apoptosis, and increased the sensitivity of prostate cancer cells to the apoptosis-inducing agent, platinol (99) . Signal transducer and activator of transcription 3 (Stat3) and Survivin have been shown to exert oncogenic effects in various human neoplasms (100) . Global gene expression analysis shows that BIRC5, or Survivin, an anti-apoptotic oncofetal gene, is highly expressed in human embryonic stem (hES) cells and teratomas but not in embryoid bodies. Genetic and pharmacological ablation of Survivin induces apoptosis in hES cells and in teratomas both in vitro and in vivo.
